Skip to main content

Electrophysiological effects of ULFS 49 CL

  • Conference paper
Sinus node inhibitors

Abstract

Pharmacologically, a decrease in sinus heart rate can be achieved by several means: indirectly, via inhibition of the autonomic nervous system, and directly at the pacemaker cells of the atrial sinus node. The term “Specific Bradycardic Agents” has been proposed for drugs which directly decrease the sinus rate in doses or concentrations smaller than are necessary to elicit other pharmacological effects [1, 7, 9, 10, 13]. ULFS 49 CL is such a new, specific, negative chronotropic agent which directly decreases the spontaneous heart rate by slowing the diastolic depolarization of the pacemaker cells in the sinu-atrial node [6, 8, 11].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bouman LN, Ginneken A van, Opthof T, Duivenvoorden JJ (1986) Electrophysiology of sinoatrial node and the action of specific bradycardic agents (SBA), a novel approach to cardiac physiology and therapy. International workshop at the Ernst Boehringer Institut, Bender u. Co

    Google Scholar 

  2. Buckberg GD, Fixier DE, Archie JP, Hoffman JIE (1972) Experimental subendocardial ischemia in dogs with normal coronary arteries. Circ Res, 30: 67–81

    PubMed  CAS  Google Scholar 

  3. Buckberg GD, Fixier DE, Archie JP, Henney RP, Hoffman JIE (1975) Variable effects of heart rate on phasic and regional left ventricular muscle blood flow in anesthetized dogs. Cardiovasc Res 9: 1–11

    Article  PubMed  CAS  Google Scholar 

  4. Connoly ME, Kersting F, Dollery CT (1976) The clinical pharmacology of beta-adrenergic blocking drugs. Prog Cardiovasc Dis 19: 203–49

    Article  Google Scholar 

  5. Dämmgen JW, Lamping KA, Gross GJ (1985) Action of two new bradycardic agents, AQ-AH 208 and ULFS 49, on ischemic myocardial perfusion and function. J Cardiovasc Pharmacol 7: 71–79

    Article  PubMed  Google Scholar 

  6. Gruber R, Lumper G, Zilberszac A, Heistracher P (1983) Effects of ULFS 49 CL on the action potential of the guinea-pig heart. Naunyn-Schmiedeberg’s Arch. Pharmacol. 324, R 32

    Google Scholar 

  7. Heistracher P (1986) Specific bradycardic agents: Introduction; specific bradycardic agents, a novel approach to cardiac physiology and therapy. International workshop at the Ernst-Boehringer-Institut, Bender u. Co

    Google Scholar 

  8. Kobinger W, Lillie C (1984a) Cardiovascular characterization of ULFS 49 CL, a new “specific bradycardic agent”. Eur. J. Pharmacol. 104: 9–18

    Article  PubMed  CAS  Google Scholar 

  9. Kobinger W, Lillie C (1984b) New Drugs Annual: Cardiovascular Drugs, Vol. 2, Chapter 10, 193–210, ed. by Alexander Scriabine, Raven Press, New York

    Google Scholar 

  10. Kobinger W (1985) Specific bradycardic agents, a new approach to therapy in angina pectoris? Prog Pharmacol 5 (3), 89–100

    CAS  Google Scholar 

  11. Lillie C, Kobinger W (1983) Cardiovascular actions of ULFS 49, a new “specific bradycardic agent”, Naunyn-Schmiedeberg’s Arch. Pharmacol. 324, R 33

    Google Scholar 

  12. Mc Allister RG Jr. (1982) Clinical pharmacology of slow channel calcium blocking agents. Prog Cardiovasc Dis 25: 83–102

    Article  CAS  Google Scholar 

  13. Reiffen M (1985) Specific bradycardic agents—a new principle in coronary heart disease 189th ACS National Meeting, American Chemical Society, Division of Medical Chemistry Abstr 41

    Google Scholar 

  14. Senges Rizos I, Brachmann J, Anders G, Jauerning R, Hamman H-D, Kübler W (1983) Effect of nifedipine and AQ-A39 on the sinoatrial and atrioventricular nodes of the rabbit and their antiarrhythmic action on atrioventricular nodal reentrant tachycardia. Cardiovasc Res 17: 132–144

    Article  Google Scholar 

  15. Sonnenblick EH; Skeleton CL (1971) Oxygen consumption of the heart: Physiological principles and clinical implications. Mod concepts Cardiovasc Dis 40, 9–16

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Seidl, K., Hauer, B., Lengfelder, W., Senges, J. (1991). Electrophysiological effects of ULFS 49 CL. In: Hjalmarson, Å., Remme, W.J. (eds) Sinus node inhibitors. Steinkopff. https://doi.org/10.1007/978-3-642-72458-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72458-9_4

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-0861-3

  • Online ISBN: 978-3-642-72458-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics